Featured Story | By Nick Paul Taylor Pfizer has returned the commercial rights to topical pain drug Flector to its original developer. The developer, IBSA Pharma, said it has lowered the price of Flector to make it one of the cheapest diclofenac topical systems available in the U.S. read more |
| |
|---|
|
Top Stories By Nick Paul Taylor Amneal Pharmaceuticals has struck a deal to buy a 98% stake in Kashiv Specialty Pharmaceuticals for $70 million upfront. The takeover will give Amneal control of drug delivery platforms and a pipeline of 505(b)(2) drugs and complex generics. read more By Nick Paul Taylor Arcutis Biotherapeutics has begun phase 3 clinical trials of its topical roflumilast cream in patients with atopic dermatitis. The product consists of the active ingredient in AstraZeneca’s oral lung drug Daliresp formulated into a cream for use on the skin of patients with a common form of eczema. read more By Nick Paul Taylor Glaukos’ intraocular implant has performed comparably to topical timolol in the 24-month interim analysis of glaucoma patients enrolled in a phase 2b trial. The study is part of Glaukos’ preparations for a planned filing for FDA approval of the iDose TR sustained-release implant. read more By Conor Hale Philips and Germany’s Merck KGaA have launched a multi-year partnership to help bring digital technologies to fertility treatments—combining informatics and mobile ultrasound diagnostics. read more |  | Survey Report: Direct-to-Patient Supply for Recruitment and Retention of Study Patients Direct-to-patient distribution of clinical supplies can reduce or even eliminate the need for patients to travel to clinical trial sites, addressing a well-known barrier related to the successful recruitment and retention of study subjects. To better understand sponsors’ perspectives on DTP and interest in using it in their studies, Catalent and FiercePharma surveyed 234 individuals involved in clinical supply and operations. Download Now. |
Resources Sponsored By: Polpharma Biologics Innovative cell lines and early process development are critical to generate a high producing cell lines alongside a USP strategy to meet high quality standards. Sponsored By: Blue Matter Biopharma companies in rare diseases: How to maximize the odds of success by becoming a valued member of the unique “rare disease ecosystem.” Sponsored by: Metabolon Learn six ways metabolomics provides greater confidence, higher success rates and complements the work of your in-house teams for your drug development pipeline. Sponsored by: Covance Download the whitepaper to learn how your safety organization can implement automation technologies to enable process and cost efficiencies, improve resource allocation and ensure compliance and quality. Sponsored By: BBK Worldwide The BBK Worldwide Study Voices 2020 survey gives voice to the healthcare consumer in the wake of COVID-19 and reveals important insights for clinical trial enrollment and engagement. Sponsored by: Rousselot This infographic describes the benefits of GelMA in various biomedical applications and how X-Pure® GelMA can help you in your developments. Sponsored by: Aldevron Gene and cell therapy organizations are asked to balance the need for rapid clinical progression and stringent quality expectations throughout development. In this document, Aldevron provides an in-depth look at preparing for plasmid manufacturing based on our years of experience. Sponsored By: Outer Edge Technology A sound Cloud Strategy provides the flexibility and tools businesses need to quickly adapt and operate securely in an ever-changing remote work environment. Learn how your company can cost-effectively empower its employees to be productive and secure while working remotely. Sponsored by: Catalent Learn about drug product process development challenges and risks, the difference between innovator and biosimilar drug product process development, and more during the drug product process development phase. Sponsored by: Catalent Learn about proven strategies for a successful product launch, including cross-functional team collaboration, risk management and using the right project management tools. Sponsored by: Catalent This eBook provides insights on key approaches and considerations for preparing your drug development program for long-term success. Sponsored by: Catalent In this webinar, pharmaceutical scientists present real-life examples of challenges they’ve overcome in the transfer of oral small molecules from a dedicated early-phase development site to a dedicated late-phase manufacturing site. Sponsored by: Catalent Get insights on key considerations for a successful tech transfer process for manufacturing a biologic drug product, including a case study on overcoming challenges in a process transfer for a sterile diluent. Sponsored by: Catalent In a BioPharma Dive industry survey, planning and forecasting were identified as top concerns for trial sponsors. In response to this need, the CSM team at Catalent has developed a methodology for identifying, evaluating, and proactively managing the inherent risks involved in clinical trial supply chain management. | 
.png)
